Objectives: Evaluation of the outcome of early hemostatic management of disseminated intravascular coagulopathy in patients with severe sepsis/septic shock admitted to PICU, before the development of clinically overt disseminated intravascular coagulopathy.
Design: Prospective interventional, open label randomized controlled clinical trial.
Setting: PICU at Alexandria University Children's Hospital.